We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Auna's Mexico Operations Stabilize in Q4: How the Path Ahead Looks
Read MoreHide Full Article
Key Takeaways
Auna's Mexico revenues fell 3% in Q4 local currency but stayed flat sequentially, signaling stabilization.
AUNA's oncology revenues jumped 35% sequentially on Opcion Oncologia integration and a new Oncocenter launch
Auna extended the ISSSTELEON plan with a double-digit price hike and insurer incentives for oncology care.
Auna S.A. (AUNA - Free Report) reported its fourth-quarter 2025 results this week. Soft market conditions in Mexico weighed on the number of surgeries and emergency visits, leading to a 3% decline in revenues in local currency. Revenues were flat compared to the previous quarter, indicating that operations in Mexico have begun to stabilize. According to the company, the business is now positioned to sustain top-line and EBITDA growth in 2026.
Oncology revenues in the quarter increased 35% on a sequential basis, supported by the continued integration of Opcion Oncologia and the launch of a new Oncocenter at Doctors Hospital. Early signs of Mexico’s recovery are also reflected in the Out-of-Pocket segment, where revenues reached 12% of the total Mexico revenues in December and rose 8% from the third quarter. This growth helped offset some of the legacy volume and margin pressures tied to physician and supplier relationships.
Under a new leadership team in Mexico, the company started implementing actions late in the year, aimed at expanding reach into the larger segments of privately insured families and strengthening alignment with physician groups. Auna secured favorable tier classifications with two of the market’s leading insurers and confirmed other tier classifications, which are expected to result in growing volumes across key service lines.
The company was awarded an extension of an improved healthcare plan for ISSSTELEON — the social security institution covering all state employees of the state of Nuevo Leon. Other initiatives to grow and diversify revenues with attractive margins are also gaining traction.
In the fourth quarter, approximately 250 physicians — accounting for about 80% of revenues in the hospital network — confirmed volume and margin improvement. These alignment incentives are supporting higher productivity, improved clinical outcomes and stronger operating performance.
AUNA’s Peer Updates
Ardent Health’s (ARDT - Free Report) total revenues fell 0.1% year over year to $1.61 million in the fourth quarter of 2025.Adjusted admissions rose 2%. However, a 2.4% decrease in net patient service revenue per adjusted admission offset the gain.Adjusted for the New Mexico state-directed payment program, which included two quarters of financial benefit in the prior-year quarter, Ardent Health’s total revenues grew roughly 3%.
AdaptHealth Corp. (AHCO - Free Report) posted net revenues of $846.3 million in the fourth quarter of 2025, down 1.2% year over year. However, the company set patient census records in Sleep Health, Respiratory Health and Wellness at Home, and a retention record in Diabetes Health. AdaptHealth also advanced digital patient engagement and expanded self-service capabilities, more than doubling myApp users to 327,300 from the year-ago quarter’s levels.
AUNA Stock Performance, Valuation and Estimates
In the past three months, Auna shares have risen 14.1% against the industry’s 7.6% fall.
Image Source: Zacks Investment Research
Auna is trading at a forward, 12-month price-to-sales (P/S) of 0.28X, lower than its median and industry average.
Image Source: Zacks Investment Research
Estimates for Auna’s earnings are showing an upward trend, as you can see below.
View the Zacks #1 Rank List
Image: Bigstock
Auna's Mexico Operations Stabilize in Q4: How the Path Ahead Looks
Key Takeaways
Auna S.A. (AUNA - Free Report) reported its fourth-quarter 2025 results this week. Soft market conditions in Mexico weighed on the number of surgeries and emergency visits, leading to a 3% decline in revenues in local currency. Revenues were flat compared to the previous quarter, indicating that operations in Mexico have begun to stabilize. According to the company, the business is now positioned to sustain top-line and EBITDA growth in 2026.
Oncology revenues in the quarter increased 35% on a sequential basis, supported by the continued integration of Opcion Oncologia and the launch of a new Oncocenter at Doctors Hospital. Early signs of Mexico’s recovery are also reflected in the Out-of-Pocket segment, where revenues reached 12% of the total Mexico revenues in December and rose 8% from the third quarter. This growth helped offset some of the legacy volume and margin pressures tied to physician and supplier relationships.
Under a new leadership team in Mexico, the company started implementing actions late in the year, aimed at expanding reach into the larger segments of privately insured families and strengthening alignment with physician groups. Auna secured favorable tier classifications with two of the market’s leading insurers and confirmed other tier classifications, which are expected to result in growing volumes across key service lines.
The company was awarded an extension of an improved healthcare plan for ISSSTELEON — the social security institution covering all state employees of the state of Nuevo Leon. Other initiatives to grow and diversify revenues with attractive margins are also gaining traction.
In the fourth quarter, approximately 250 physicians — accounting for about 80% of revenues in the hospital network — confirmed volume and margin improvement. These alignment incentives are supporting higher productivity, improved clinical outcomes and stronger operating performance.
AUNA’s Peer Updates
Ardent Health’s (ARDT - Free Report) total revenues fell 0.1% year over year to $1.61 million in the fourth quarter of 2025.Adjusted admissions rose 2%. However, a 2.4% decrease in net patient service revenue per adjusted admission offset the gain.Adjusted for the New Mexico state-directed payment program, which included two quarters of financial benefit in the prior-year quarter, Ardent Health’s total revenues grew roughly 3%.
AdaptHealth Corp. (AHCO - Free Report) posted net revenues of $846.3 million in the fourth quarter of 2025, down 1.2% year over year. However, the company set patient census records in Sleep Health, Respiratory Health and Wellness at Home, and a retention record in Diabetes Health. AdaptHealth also advanced digital patient engagement and expanded self-service capabilities, more than doubling myApp users to 327,300 from the year-ago quarter’s levels.
AUNA Stock Performance, Valuation and Estimates
In the past three months, Auna shares have risen 14.1% against the industry’s 7.6% fall.
Image Source: Zacks Investment Research
Auna is trading at a forward, 12-month price-to-sales (P/S) of 0.28X, lower than its median and industry average.
Image Source: Zacks Investment Research
Estimates for Auna’s earnings are showing an upward trend, as you can see below.
Image Source: Zacks Investment Research
AUNA stock sports a Zacks Rank #1 (Strong Buy) at present.You can see the complete list of today’s Zacks #1 Rank stocks here.